DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 37 filers reported holding DIAMEDICA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $564,597 | -29.3% | 218,778 | +18.3% | 0.00% | – |
Q2 2023 | $798,638 | +182.4% | 184,870 | 0.0% | 0.00% | – |
Q1 2023 | $282,851 | +96766.8% | 184,870 | 0.0% | 0.00% | – |
Q4 2022 | $292 | -99.9% | 184,870 | -0.2% | 0.00% | – |
Q3 2022 | $229,000 | -35.9% | 185,219 | +4.6% | 0.00% | – |
Q2 2022 | $357,000 | -18.3% | 177,022 | +1.2% | 0.00% | – |
Q1 2022 | $437,000 | -30.1% | 174,858 | +4.2% | 0.00% | – |
Q4 2021 | $625,000 | -7.0% | 167,763 | 0.0% | 0.00% | – |
Q3 2021 | $672,000 | +13.1% | 167,763 | +25.6% | 0.00% | – |
Q2 2021 | $594,000 | -49.4% | 133,569 | +4.0% | 0.00% | – |
Q1 2021 | $1,175,000 | +11.8% | 128,468 | +23.9% | 0.00% | – |
Q4 2020 | $1,051,000 | +296.6% | 103,699 | +65.5% | 0.00% | – |
Q3 2020 | $265,000 | -32.1% | 62,662 | +11.1% | 0.00% | – |
Q2 2020 | $390,000 | +142.2% | 56,412 | -1.9% | 0.00% | – |
Q1 2020 | $161,000 | -5.3% | 57,524 | +63.8% | 0.00% | – |
Q4 2019 | $170,000 | +448.4% | 35,114 | +128.0% | 0.00% | – |
Q3 2019 | $31,000 | – | 15,399 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 1,197,245 | $2,993,000 | 1.24% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 265,000 | $663,000 | 0.40% |
COOPERMAN LEON G | 812,508 | $2,031,270 | 0.11% |
Ikarian Capital, LLC | 221,252 | $553,000 | 0.07% |
Shay Capital LLC | 10,000 | $25,000 | 0.00% |
Sandy Cove Advisors, LLC | 1,200 | $3,000 | 0.00% |
BOOTHBAY FUND MANAGEMENT, LLC | 20,603 | $52,000 | 0.00% |
Newbridge Financial Services Group, Inc. | 1,269 | $3,000 | 0.00% |
Patriot Financial Group Insurance Agency, LLC | 1,300 | $3,000 | 0.00% |
GROUP ONE TRADING, L.P. | 20 | $0 | 0.00% |